What is the recommended treatment for suspected or confirmed Yersinia pestis infection, including alternatives for pregnant patients and severe pneumonic plague?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yersinia pestis (Plague) Treatment

Start immediate parenteral therapy with a fluoroquinolone (levofloxacin 750 mg IV q24h or ciprofloxacin 400 mg IV q8h) or an aminoglycoside (gentamicin 5 mg/kg IV/IM q24h) for 10–14 days; in pregnancy, use dual therapy with gentamicin plus a fluoroquinolone; add chloramphenicol if meningitis; escalate to dual active classes for severe pneumonic plague. 1

Algorithm (prioritizing mortality and QOL)

  • Suspected or confirmed plague (any form)

    • Begin immediately (do not wait for labs) with one of:
      • Levofloxacin 750 mg IV q24h (preferred fluoroquinolone) 1
      • Ciprofloxacin 400 mg IV q8h 1
      • Gentamicin 5 mg/kg IV/IM q24h (preferred aminoglycoside) 1
    • Duration: 10–14 days; switch to oral when clinically stable (except ciprofloxacin cannot be via NG/GT) 1
    • Parenteral route preferred initially for all patients 1
  • Severe pneumonic plague, sepsis, or rapid deterioration

    • Use dual therapy from distinct classes to reduce early mortality risk:
      • Gentamicin 5 mg/kg IV/IM q24h PLUS levofloxacin 750 mg IV q24h (or ciprofloxacin 400 mg IV q8h) 1
    • ICU-level supportive care; maintain full 10–14 days 1
  • Pregnancy (any form, including pneumonic)

    • First-line: Dual therapy
      • Gentamicin 5 mg/kg IV/IM q24h PLUS
        • Ciprofloxacin 400 mg IV q8h or 500 mg PO q8h, OR
        • Levofloxacin 750 mg IV/PO q24h
    • Rationale: Maximizes maternal survival; gentamicin favored over streptomycin due to fetal ototoxicity risk with streptomycin; fluoroquinolones acceptable in pregnancy based on safety data 1
    • Route: Prefer parenteral initially due to reduced GI absorption in pregnancy 1
    • If secondary plague meningitis: ADD chloramphenicol 12.5–25 mg/kg IV q6h (monitor levels; use lower end when possible) 1
  • Alternatives (if intolerance/contraindications or limited availability)

    • Moxifloxacin 400 mg IV/PO q24h; ofloxacin 400 mg PO q12h 1
    • Doxycycline: 200 mg IV load, then 100 mg IV/PO q12h (pregnancy: alternative status) 1
    • TMP-SMX: 5 mg/kg (TMP) IV/PO q8h 1
    • Aminoglycoside alternatives: amikacin 15–20 mg/kg IV/IM q24h; tobramycin 5–7 mg/kg IV/IM q24h; plazomicin 15 mg/kg IV q24h (availability may vary) 1
    • Streptomycin 1 g IV/IM q12h (avoid in pregnancy if possible due to irreversible fetal ototoxicity) 1

Key nuances and pitfalls

  • Early treatment saves lives: untreated pregnancy cases had very high maternal and fetal mortality; appropriate antimicrobials markedly reduce maternal death, though fetal loss risk remains high—act immediately to improve mortality and QOL 2.
  • For pregnancy, dual therapy is explicitly recommended; do not use streptomycin unless no other option due to fetal toxicity; monitor aminoglycoside levels and adjust dosing, especially with physiologic changes in pregnancy 1.
  • Chloramphenicol is indicated when meningitis suspected/confirmed due to CNS penetration; use therapeutic drug monitoring and minimize dose when feasible to avoid toxicity 1.
  • Resistance is rare but reported; if clinical failure or known resistance, ensure dual active classes and obtain susceptibilities; consider alternative fluoroquinolones (e.g., delafloxacin) if available 1, 3.
  • All oral options (except ciprofloxacin) can be given via NG/GT if needed; start parenteral first in severe disease for reliable exposure 1.

Dosing summary (adults; 10–14 days) 1

  • Levofloxacin 750 mg IV/PO q24h
  • Ciprofloxacin 400 mg IV q8h or 500 mg PO q8h
  • Gentamicin 5 mg/kg IV/IM q24h (monitor levels)
  • If meningitis: add chloramphenicol 12.5–25 mg/kg IV q6h (max 1 g/dose), aim lower end and monitor

Evidence strength: 2021 CDC MMWR Recommendations and Reports (guideline) are the most recent, high-quality, and directly applicable for treatment selection and special populations, including pregnancy and severe pneumonic plague 1. Systematic reviews support mortality benefits of timely appropriate therapy and inform safety in pregnancy 2, 4.

References

Research

Plague During Pregnancy: A Systematic Review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020

Research

Yersinia pestis antibiotic resistance: a systematic review.

Osong public health and research perspectives, 2022

Research

Antimicrobial Treatment of Human Plague: A Systematic Review of the Literature on Individual Cases, 1937-2019.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.